Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 3,868 shares at $70.05 ($271K) on 2016-04-08, disclosed to the SEC on 2016-04-11.
Open-market sale of $271k ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAC | SELL | 2016-04-11 | $16.0M | — | Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |